GIDARI, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 430
EU - Europa 300
AS - Asia 169
SA - Sud America 9
Totale 908
Nazione #
US - Stati Uniti d'America 428
IT - Italia 153
IE - Irlanda 88
SG - Singapore 85
HK - Hong Kong 52
CN - Cina 19
DE - Germania 12
KR - Corea 10
AT - Austria 8
BR - Brasile 8
FR - Francia 7
FI - Finlandia 6
RU - Federazione Russa 4
UA - Ucraina 4
BE - Belgio 3
CZ - Repubblica Ceca 3
NL - Olanda 3
ES - Italia 2
GB - Regno Unito 2
SE - Svezia 2
AZ - Azerbaigian 1
BD - Bangladesh 1
CA - Canada 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
GR - Grecia 1
LV - Lettonia 1
TH - Thailandia 1
Totale 908
Città #
Chandler 99
Dublin 88
Perugia 75
Singapore 68
Hong Kong 52
Boardman 35
Santa Clara 29
San Mateo 20
Redmond 19
Wilmington 17
Altamura 13
Medford 12
Princeton 12
Lawrence 11
Seoul 10
Ann Arbor 8
Bastia umbra 8
Florence 7
Los Angeles 6
Helsinki 5
Andover 4
Milan 4
New York 4
Paris 4
Rome 4
Bologna 3
Brussels 3
Dallas 3
Den Haag 3
Des Moines 3
Munich 3
Nuremberg 3
Seattle 3
Tappahannock 3
Ashburn 2
Falkenstein 2
Falls Church 2
Houston 2
Madrid 2
Naples 2
Padova 2
Sinalunga 2
Vienna 2
West Jordan 2
Woodbridge 2
Alcamo 1
Anguillara Sabazia 1
Araucária 1
Baku 1
Bari 1
Beijing 1
Bogotá 1
Bom Jesus dos Perdões 1
Brno 1
Cambridge 1
Chengdu 1
Clifton 1
Edinburgh 1
Fairfield 1
Favara 1
Feira de Santana 1
Grimmen 1
Itapema 1
Jacksonville 1
Kiev 1
Kropyvnytskyi 1
Lappeenranta 1
Lausanne 1
Luhansk 1
Macaé 1
Maceió 1
Nagold 1
Norwalk 1
Olomouc 1
Pesaro 1
Piraeus 1
Prague 1
Quatis 1
Redwood City 1
Riga 1
San José 1
San Paolo di Civitate 1
St Petersburg 1
Stockholm 1
São Paulo 1
Toronto 1
Trento 1
Vicenza 1
Totale 706
Nome #
Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection 81
SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione 81
Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature 67
Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected 63
Impact of SARS-CoV-2 Omicron variants on serum neutralization in a cohort of healthcare workers vaccinated with BNT162b2 62
Role of nucleocapsid protein antigen detection for safe end of isolation of sars-cov-2 infected patients with long persistence of viral rna in respiratory samples 54
SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light 51
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 47
Predictive risk factors for worse outcomes in COVID-19 patients with different clinical features at baseline 44
Low brachial artery flow-mediated dilation predicts worse prognosis in hospitalized patients with covid-19 43
Tedizolid-Rifampicin Combination Prevents Rifampicin-Resistance on in vitro Model of Staphylococcus aureus Mature Biofilm 39
National Early Warning Score 2 (NEWS2) better predicts critical Coronavirus Disease 2019 (COVID-19) illness than COVID-GRAM, a multi-centre study 38
Comorbidities, cardiovascular therapies, and COVID-19 mortality: A nationwide, italian observational study (ItaliCO) 35
Pre and Post-Monoclonal Infusion Neutralizing Activity in a Subgroup of Patients Treated in the Presence of two SARS-CoV-2 Dominant Variant of Concern (VOCs) and an Ongoing Vaccination. Overall Clinical Efficacy of Two Monoclonal Antibodies Association in Umbria 32
The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In Vitro 32
Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients 31
Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir 28
Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2 23
The hope and hype of ellagic acid and urolithins as ligands of SARS-CoV-2 Nsp5 and inhibitors of viral replication 23
Nelfinavir: An Old Ally in the COVID-19 Fight? 23
Synergistic Activity of Remdesivir–Nirmatrelvir Combination on a SARS-CoV-2 In Vitro Model and a Case Report 21
BNT162b2 Elicited an Efficient Humoral Response Against Different Strains of SARS-CoV-2 in People Living with HIV 20
Tixagevimab/Cilgavimab: Still a Valid Prophylaxis against COVID-19 New Variants? 17
Protective Effect of Indole-3-Aldehyde in Murine COVID-19-Associated Pulmonary Aspergillosis 15
Chronic antibiotic suppressive therapy with dalbavancin: a case series 14
Totale 984
Categoria #
all - tutte 6.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.106


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 0 0 0 0 0 4
2020/202167 0 2 6 7 7 3 1 2 2 19 1 17
2021/2022108 6 19 3 2 4 5 1 17 7 6 24 14
2022/2023328 12 45 5 49 29 26 3 15 122 0 17 5
2023/2024176 7 21 5 2 4 4 57 1 12 11 28 24
2024/2025301 15 38 16 32 33 44 88 35 0 0 0 0
Totale 984